MRI contrast developer Epix Medical of Cambridge, MA, has signed an agreement with Acqua Wellington North American Equities Fund, which will provide an equity financing facility to sell up to $45 million of Epix common stock over the next 28 months.
The stock may be sold at a small discount to the market price of the shares at the time of the sale, Epix said. The total amount of the investment depends in part on Epix’s stock price, with the firm controlling the amount and timing of stock sold.
By AuntMinnie.com staff writersSeptember 19, 2000
Related Reading
Epix net loss widens despite Q2 revenue surge, July 21, 2000
Schering, Epix, Mallinckrodt exchange rights for cardiac MRI agent, June 9, 2000
Epix, Schering end patent dispute, May 9, 2000
Copyright © 2000 AuntMinnie.com
